Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure
Background: As of 8 April 2021, a total of 2.9 million people have died with or from the coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021, the European Medicines Agency (EMA) approved a COVID-19 vaccine developed by Oxford University and AstraZeneca (AZD1222, Ch...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
9 April 2021
|
| In: |
Journal of Clinical Medicine
Year: 2021, Jahrgang: 10, Heft: 8, Pages: 1-10 |
| ISSN: | 2077-0383 |
| DOI: | 10.3390/jcm10081599 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/jcm10081599 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2077-0383/10/8/1599 
|
| Verfasserangaben: | Marc E. Wolf, Beate Luz, Ludwig Niehaus, Pervinder Bhogal, Hansjörg Bäzner and Hans Henkes |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1767100493 | ||
| 003 | DE-627 | ||
| 005 | 20230426082438.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210816s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm10081599 |2 doi | |
| 035 | |a (DE-627)1767100493 | ||
| 035 | |a (DE-599)KXP1767100493 | ||
| 035 | |a (OCoLC)1341420668 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wolf, Marc |d 1979- |e VerfasserIn |0 (DE-588)132427141 |0 (DE-627)52269117X |0 (DE-576)299138887 |4 aut | |
| 245 | 1 | 0 | |a Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure |c Marc E. Wolf, Beate Luz, Ludwig Niehaus, Pervinder Bhogal, Hansjörg Bäzner and Hans Henkes |
| 264 | 1 | |c 9 April 2021 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.08.2021 | ||
| 520 | |a Background: As of 8 April 2021, a total of 2.9 million people have died with or from the coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021, the European Medicines Agency (EMA) approved a COVID-19 vaccine developed by Oxford University and AstraZeneca (AZD1222, ChAdOx1 nCoV-19, COVID-19 vaccine AstraZeneca, Vaxzevria, Covishield). While the vaccine prevents severe course of and death from COVID-19, the observation of pulmonary, abdominal, and intracranial venous thromboembolic events has raised concerns. Objective: To describe the clinical manifestations and the concerning management of patients with cranial venous sinus thrombosis following first exposure to the “COVID-19 vaccine AstraZeneca”. Methods: Patient files, laboratory findings, and diagnostic imaging results, and endovascular interventions of three concerning patients were evaluated in retrospect. Results: Three women with intracranial venous sinus thrombosis after their first vaccination with “COVID-19 vaccine AstraZeneca” were encountered. Patient #1 was 22 years old and developed headaches four days after the vaccination. On day 7, she experienced a generalized epileptic seizure. Patient #2 was 46 years old. She presented with severe headaches, hemianopia to the right, and mild aphasia 13 days after the vaccination. MRI showed a left occipital intracerebral hemorrhage. Patient #3 was 36 years old and presented 17 days after the vaccination with acute somnolence and right-hand hemiparesis. The three patients were diagnosed with extensive venous sinus thrombosis. They were managed by heparinization and endovascular recanalization of their venous sinuses. They shared similar findings: elevated levels of D-dimers, platelet factor 4 antiplatelet antibodies, corona spike protein antibodies, combined with thrombocytopenia. Under treatment with low-molecular-weight heparin, platelet counts normalized within several days. Conclusion: Early observations insinuate that the exposure to the “COVID-19 vaccine AstraZeneca” might trigger the expression of antiplatelet antibodies, resulting in a condition with thrombocytopenia and venous thrombotic events (e.g., intracranial venous sinus thrombosis). These patients’ treatment should address the thrombo-embolic manifestations, the coagulation disorder, and the underlying immunological phenomena. | ||
| 650 | 4 | |a anticoagulation | |
| 650 | 4 | |a COVID-19 vaccine AstraZeneca | |
| 650 | 4 | |a platelet factor 4 antibodies | |
| 650 | 4 | |a rheolysis | |
| 650 | 4 | |a venous sinus thrombosis | |
| 700 | 1 | |a Luz, Beate |e VerfasserIn |4 aut | |
| 700 | 1 | |a Niehaus, Ludwig |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bhogal, Pervinder |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bäzner, Hansjörg |e VerfasserIn |0 (DE-588)1031161775 |0 (DE-627)735747873 |0 (DE-576)174519311 |4 aut | |
| 700 | 1 | |a Henkes, Hans |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Clinical Medicine |d Basel : MDPI, 2012 |g 10(2021), 8, Artikel-ID 1599, Seite 1-10 |h Online-Ressource |w (DE-627)718632478 |w (DE-600)2662592-1 |w (DE-576)365782718 |x 2077-0383 |7 nnas |a Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:8 |g elocationid:1599 |g pages:1-10 |g extent:10 |a Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure |
| 856 | 4 | 0 | |u https://doi.org/10.3390/jcm10081599 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2077-0383/10/8/1599 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210816 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1031161775 |a Bäzner, Hansjörg |m 1031161775:Bäzner, Hansjörg |d 60000 |e 60000PB1031161775 |k 0/60000/ |p 5 | ||
| 998 | |g 132427141 |a Wolf, Marc |m 132427141:Wolf, Marc |d 60000 |d 62700 |e 60000PW132427141 |e 62700PW132427141 |k 0/60000/ |k 1/60000/62700/ |p 1 |x j | ||
| 999 | |a KXP-PPN1767100493 |e 3969320410 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 16.08.2021"],"language":["eng"],"recId":"1767100493","title":[{"title_sort":"Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure","title":"Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure"}],"person":[{"roleDisplay":"VerfasserIn","display":"Wolf, Marc","role":"aut","family":"Wolf","given":"Marc"},{"family":"Luz","given":"Beate","roleDisplay":"VerfasserIn","display":"Luz, Beate","role":"aut"},{"family":"Niehaus","given":"Ludwig","roleDisplay":"VerfasserIn","display":"Niehaus, Ludwig","role":"aut"},{"role":"aut","display":"Bhogal, Pervinder","roleDisplay":"VerfasserIn","given":"Pervinder","family":"Bhogal"},{"display":"Bäzner, Hansjörg","roleDisplay":"VerfasserIn","role":"aut","family":"Bäzner","given":"Hansjörg"},{"display":"Henkes, Hans","roleDisplay":"VerfasserIn","role":"aut","family":"Henkes","given":"Hans"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"origin":[{"dateIssuedKey":"2012","publisher":"MDPI","dateIssuedDisp":"2012-","publisherPlace":"Basel"}],"id":{"zdb":["2662592-1"],"eki":["718632478"],"issn":["2077-0383"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"open access journal","title":"Journal of Clinical Medicine","title_sort":"Journal of Clinical Medicine"}],"note":["Gesehen am 12.06.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposureJournal of Clinical Medicine","language":["eng"],"recId":"718632478","pubHistory":["1.2012 -"],"part":{"year":"2021","pages":"1-10","issue":"8","text":"10(2021), 8, Artikel-ID 1599, Seite 1-10","volume":"10","extent":"10"}}],"origin":[{"dateIssuedDisp":"9 April 2021","dateIssuedKey":"2021"}],"id":{"eki":["1767100493"],"doi":["10.3390/jcm10081599"]},"name":{"displayForm":["Marc E. Wolf, Beate Luz, Ludwig Niehaus, Pervinder Bhogal, Hansjörg Bäzner and Hans Henkes"]}} | ||
| SRT | |a WOLFMARCLUTHROMBOCYT9202 | ||